How does tafenoquine prevent malaria from coming back?
Tafenoquine kills dormant malaria parasites (called hypnozoites) hiding in your liver. A single 300 mg dose eliminates these parasites in 94% of patients, preventing relapse for 3+ years [2][6].
Malaria caused by Plasmodium vivax has two stages: the acute blood infection you feel (fever, chills, sweats) and dormant liver parasites that wake up weeks or months later, causing relapse. Tafenoquine is an 8-aminoquinoline—a chemical class that penetrates liver cells and kills hypnozoites that other antimalarials miss [6]. Clinical trials show 94% relapse prevention with a single 300 mg dose, compared to 80% with primaquine taken daily for 14 days [2].
Inside your liver cells, tafenoquine disrupts the parasite's electron transport chain—the energy factory that keeps it alive. This mechanism is the same as primaquine, but tafenoquine's longer half-life (14–16 days) means it stays in your body longer, delivering a more complete kill of dormant parasites [6]. Your liver breaks down tafenoquine over 2–3 weeks; the drug reaches peak blood levels within 24 hours of taking it [9].
The real-world trade-off is convenience versus side effects. One pill beats 14 days of primaquine pills, but tafenoquine's longer half-life means any side effects (nausea, headache, hemolysis in G6PD-deficient patients) last longer [1]. If you have G6PD deficiency, tafenoquine is contraindicated because the cumulative drug exposure over 2–3 weeks can trigger severe hemolysis—a dangerous breakdown of red blood cells [1].
Ask your doctor: 'Do I need a G6PD blood test before taking tafenoquine?' If you have this genetic enzyme defect, primaquine or atovaquone-proguanil may be safer alternatives. Get the test result in writing before your pharmacy fills the prescription [1].